Comvita Raises Capital, Secures Refinancing and Brings Fraser and Neave on Board

An update from Comvita ( (CVNZF) ) is now available.

Comvita has launched a pro-rata renounceable rights offer of up to NZ$30 million at NZ$0.65 per share, partially underwritten by F&N Ventures, a subsidiary of Singapore’s Fraser and Neave, Limited, which will become a strategic shareholder with up to 19.99% of the company via the offer and a potential placement at a premium price. The capital raise, which could reach NZ$44 million when combined with the strategic placement, will be used to repay existing bank debt and unlock a new refinancing package comprising a NZ$20 million working capital facility and up to NZ$30 million in core debt maturing in 2028, while Comvita and F&N plan to explore cooperation in ASEAN market expansion, digital, data, innovation and supply-chain efficiencies, including an F&N-nominated director joining the board.

More about Comvita

Comvita Limited is a New Zealand-listed natural health products company best known for its mānuka honey and related wellness offerings. The business focuses on premium consumer health brands with strong exposure to Asia-Pacific markets, and is seeking to deepen its presence in high-growth regions such as ASEAN via strategic partnerships and enhanced distribution channels.

For an in-depth examination of CVNZF stock, go to TipRanks’ Overview page.